190 related articles for article (PubMed ID: 25658637)
21. Major role of the soluble interleukin-6/interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines.
Gaillard JP; Liautard J; Klein B; Brochier J
Eur J Immunol; 1997 Dec; 27(12):3332-40. PubMed ID: 9464821
[TBL] [Abstract][Full Text] [Related]
22. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment.
Dijkgraaf EM; Heusinkveld M; Tummers B; Vogelpoel LT; Goedemans R; Jha V; Nortier JW; Welters MJ; Kroep JR; van der Burg SH
Cancer Res; 2013 Apr; 73(8):2480-92. PubMed ID: 23436796
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells.
Santer FR; Malinowska K; Culig Z; Cavarretta IT
Endocr Relat Cancer; 2010 Mar; 17(1):241-53. PubMed ID: 19966016
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial fission enhances IL-6-induced metastatic potential in ovarian cancer via ERK1/2 activation.
Lee J; Han Y; Kim S; Jo H; Wang W; Cho U; Kim SI; Kim B; Song YS
Cancer Sci; 2024 May; 115(5):1536-1550. PubMed ID: 38433313
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium.
Liu Z; Sakamoto T; Ezure T; Yokomuro S; Murase N; Michalopoulos G; Demetris AJ
Hepatology; 1998 Nov; 28(5):1260-8. PubMed ID: 9794910
[TBL] [Abstract][Full Text] [Related]
27. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
[TBL] [Abstract][Full Text] [Related]
28. Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.
Mizutani Y; Bonavida B; Koishihara Y; Akamatsu K; Ohsugi Y; Yoshida O
Cancer Res; 1995 Feb; 55(3):590-6. PubMed ID: 7834629
[TBL] [Abstract][Full Text] [Related]
29. Effect of macrophages on biological function of ovarian cancer cells in tumor microenvironment in vitro.
Yi J; Lin Y; Yicong W; Chengyan L; Shulin Z; Wenjun C
Arch Gynecol Obstet; 2020 Oct; 302(4):1009-1017. PubMed ID: 32748054
[TBL] [Abstract][Full Text] [Related]
30. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
Nakahara H; Song J; Sugimoto M; Hagihara K; Kishimoto T; Yoshizaki K; Nishimoto N
Arthritis Rheum; 2003 Jun; 48(6):1521-9. PubMed ID: 12794819
[TBL] [Abstract][Full Text] [Related]
31. Role of the interleukin 6 receptor family in epithelial ovarian cancer and its clinical implications.
Kumar J; Ward AC
Biochim Biophys Acta; 2014 Apr; 1845(2):117-25. PubMed ID: 24388871
[TBL] [Abstract][Full Text] [Related]
32. Soluble interleukin-6 receptor alpha inhibits the cytokine-Induced fractalkine/CX3CL1 expression in human vascular endothelial cells in culture.
Matsumiya T; Imaizumi T; Fujimoto K; Cui X; Shibata T; Tamo W; Kumagai M; Tanji K; Yoshida H; Kimura H; Satoh K
Exp Cell Res; 2001 Sep; 269(1):35-41. PubMed ID: 11525637
[TBL] [Abstract][Full Text] [Related]
33. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.
Matsumoto S; Hara T; Mitsuyama K; Yamamoto M; Tsuruta O; Sata M; Scheller J; Rose-John S; Kado S; Takada T
J Immunol; 2010 Feb; 184(3):1543-51. PubMed ID: 20042582
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
[TBL] [Abstract][Full Text] [Related]
35. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures.
Watson JM; Sensintaffar JL; Berek JS; Martínez-Maza O
Cancer Res; 1990 Nov; 50(21):6959-65. PubMed ID: 2208162
[TBL] [Abstract][Full Text] [Related]
36. Regulatory effect of e2, IL-6 and IL-8 on the growth of epithelial ovarian cancer cells.
Wang Y; Yang J; Gao Y; Du Y; Bao L; Niu W; Yao Z
Cell Mol Immunol; 2005 Oct; 2(5):365-72. PubMed ID: 16368063
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation.
Kotake S; Sato K; Kim KJ; Takahashi N; Udagawa N; Nakamura I; Yamaguchi A; Kishimoto T; Suda T; Kashiwazaki S
J Bone Miner Res; 1996 Jan; 11(1):88-95. PubMed ID: 8770701
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
Miao JW; Liu LJ; Huang J
Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
[TBL] [Abstract][Full Text] [Related]
39. Systemic lupus erythematosus is associated with impaired autophagic degradation via interleukin-6 in macrophages.
Hsu HC; Chen YH; Lin TS; Shen CY; Hsieh SC
Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166027. PubMed ID: 33248276
[TBL] [Abstract][Full Text] [Related]
40. A novel peptide specifically binding to interleukin-6 receptor (gp80) inhibits angiogenesis and tumor growth.
Su JL; Lai KP; Chen CA; Yang CY; Chen PS; Chang CC; Chou CH; Hu CL; Kuo ML; Hsieh CY; Wei LH
Cancer Res; 2005 Jun; 65(11):4827-35. PubMed ID: 15930303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]